ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 778 filers reported holding ASTRAZENECA PLC in Q4 2020. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $348,216 | +29.8% | 5,142 | +37.2% | 0.04% | +5.9% |
Q2 2023 | $268,244 | +3.8% | 3,748 | +0.6% | 0.03% | -20.9% |
Q1 2023 | $258,483 | -11.7% | 3,724 | -13.8% | 0.04% | -20.4% |
Q4 2022 | $292,828 | +26.2% | 4,319 | +2.2% | 0.05% | -5.3% |
Q3 2022 | $232,000 | -17.4% | 4,226 | -0.5% | 0.06% | -8.1% |
Q2 2022 | $281,000 | -4.1% | 4,249 | -3.8% | 0.06% | +3.3% |
Q1 2022 | $293,000 | -4.6% | 4,419 | -16.2% | 0.06% | -7.7% |
Q4 2021 | $307,000 | +5.1% | 5,272 | +8.3% | 0.06% | -12.2% |
Q3 2021 | $292,000 | -1.4% | 4,866 | -1.5% | 0.07% | -8.6% |
Q2 2021 | $296,000 | +23.3% | 4,938 | +2.3% | 0.08% | -24.3% |
Q1 2021 | $240,000 | -0.4% | 4,828 | 0.0% | 0.11% | -9.3% |
Q4 2020 | $241,000 | -4.0% | 4,828 | +5.3% | 0.12% | -15.7% |
Q3 2020 | $251,000 | -19.0% | 4,587 | -21.7% | 0.14% | -15.2% |
Q2 2020 | $310,000 | +14.0% | 5,855 | -4.0% | 0.16% | -8.8% |
Q1 2020 | $272,000 | -12.0% | 6,097 | -1.6% | 0.18% | -4.2% |
Q4 2019 | $309,000 | – | 6,197 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 611,665 | $35,629,000 | 8.68% |
SPHERA FUNDS MANAGEMENT LTD. | 1,055,467 | $61,481,000 | 6.76% |
Endurant Capital Management LP | 324,728 | $18,915,000 | 4.57% |
Darwin Global Management, Ltd. | 511,908 | $29,819,000 | 4.56% |
SAL Trading, LLC | 188,276 | $10,967,000 | 4.47% |
Susquehanna International Securities, Ltd. | 126,356 | $7,360,000 | 4.45% |
ARDSLEY ADVISORY PARTNERS LP | 400,000 | $23,300,000 | 4.44% |
Avidity Partners Management LP | 2,867,200 | $167,014,000 | 3.54% |
Eversept Partners, LP | 949,224 | $55,292,298 | 3.53% |
GQG Partners LLC | 19,453,752 | $1,132,984,000 | 2.81% |